FOR IMMEDIATE RELEASE

IRVINE, Calif., September 13, 2011 – BioMedGPS, LLC, a developer of healthcare business IT solutions for life science companies, reports that the US market for shoulder replacement, which includes total, partial, and reverse shoulders, and resurfacing implants, will reach an estimated $515 million in 2011, and grow at a rate of 11% to approximately $869 million in 2015. SmartTRAK™ Shoulder Recon is the first of several offerings for the Extremities and Total Joint markets that will be launched by BioMedGPS for SmartTRAK Business Intelligence Hub, an online content-rich, interactive enterprise-wide collaboration tool for life science and medical device organizations. BioMedGPS continues to expand the content of SmartTRAK with new Extremities modules including Foot & Ankle, and Elbow, Wrist & Hand, and a Sports Medicine module launching by year end.

“The market for shoulder replacements has continued to expand with overall procedural growth and the increasing popularity of reverse shoulder replacements,” stated Lisa Mahan, Senior Analyst who oversees the SmartTRAK Extremities and Total Joints modules at BioMedGPS. “The US Shoulder Market is garnering more attention from orthopedic manufacturers because of its sustained growth well above that of the hip, knee, or spine markets. Even in this soft economic market, shoulder replacement procedures continue to grow with the aging demographics, increased patient awareness and the expanding use of reverse shoulder systems.”

BioMedGPS expects reverse shoulder systems to continue shifting the market mix away from lower cost partial shoulders for treating severe cuff tear arthropathy, driving market dollar growth. Other technologies such as shoulder resurfacing and stemless implants may expand the market for treating patients with earlier stages of shoulder joint degeneration.

Companies looking to expand their market presence, gain an understanding of market drivers, and evaluate the global competitive landscape can find the strategic information they need by subscribing to BioMedGPS's SmartTRAK Business Intelligence Hub. SmartTRAK Shoulder Recon currently monitors and analyzes 89 shoulder replacement products from 40 companies. In addition, 58 shoulder reconstruction products are monitored and analyzed including proximal humeral plating systems and IM devices bringing the total to 49 companies and 146 products.

SmartTRAK Shoulder Recon is the newest addition to SmartTRAK Business Intelligence Hub, the first enterprise-wide system that streamlines the flow and exchange of competitive market, company and product insight within an organization. SmartTRAK Shoulder Recon offers a powerful combination of real-time information, deep industry content, and analysis from domain experts on public and privately held companies developing shoulder replacement and repair products on the market or under development worldwide, along with 5-year US market forecasts. SmartTRAK Shoulder Recon is the only source for up-to-date, broadly sourced and validated business information on shoulder companies, products and the market, combined with built-in enterprise collaboration tools. Other SmartTRAK intelligence modules include OrthoBio, Spine and Wound Biologics.

About BioMedGPS, LLC
BioMedGPS, LLC provides online business intelligence and dynamic decision-making tools specifically designed for life science executives with the goal of transforming the delivery of healthcare business information increasing proficiency, improving productivity, and reducing cost. BioMedGPS is led by Sharon O’Reilly, founder and former President & CEO of Medtech Insight.

To learn more about SmartTRAK Shoulder Recon, visit http://biomedgps.com/shoulder. Subscriptions are also available for the SmartTRAK OrthoBio, Wound, and Spine modules, which together are tracking more than 400 companies and 1,530 products to date. For further information about BioMedGPS, please visit http://www.biomedgps.com.

###